Scientific publications

Rituximab in Dermatology

España A, Ornilla E [SP], Panizo C.
Departamento de Dermatología, Clínica Universidad de Navarra, Facultad de Medicina, Universidad de Navarra, Pamplona, España.

Magazine: Actas Dermosifiliográficas

Date: Jul 30, 2012

Rheumatology [SP] Haematology and Hameotherapy Dermatology


Rituximab was introduced into clinical practice as a medication with considerable potential. Its use in patients with B-cell lymphoma and rheumatoid arthritis revealed numerous indications in autoimmune diseases, many of which involve the skin, thus requiring dermatologists to become familiar with both the characteristics of anti-CD20 antibodies and the role of B cells in multiple skin diseases.

Thanks to these developments, we will be able to use rituximab more frequently and appropriately in our patients and draw up consensus guidelines based on large case series. In other words, establishing the indications for rituximab will make it possible to shorten disease course and reduce morbidity due to more specific drugs.

CITA DEL ARTICULO  Actas Dermosifiliogr. 2013;104:380-92. - Vol. 104 Núm.05 DOI: 10.1016/

you maybe interested


The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra


The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra


Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra